Bracco’s VUEWAY™ (gadopiclenol) injection now in hospitals Preeminent Hospitals and Medical Practices Nationwide Lead in Patient Care with First Use of Bracco’s VUEWAY™ (gadopiclenol) solution for injection for MRI.

Bracco announces the birth of Bracco Japan Ltd Bracco will acquire all shares of Bracco-Eisai held by Eisai and change its name from Bracco-Eisai to Bracco Japan, Ltd.  as of April 1, 2023.

AI and Radiology: mutual game changers At ECR 2023 in Vienna, we discussed what means to be Gamechangers in radiology and how this aligns with the Bracco motto “Unlocking the Invisible”.

Bracco è Marchio Storico di Interesse Nazionale L’azienda, nata nel 1927 e oggi leader globale nella diagnostica per immagini, entra a far parte dell’esclusivo gruppo di imprese storiche che rappresentano la punta di diamante del Made in Italy.

Our New Iodine Recollection Pilot and Re.Viva Re.Viva works to capture and redeploy used substances in the positive momentum of the circular economy: the Bracco Iodine Recollection Pilot 

Data Reinforcing Efficacy and Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions Published in Radiology

Diagnostic challenges of benign/incidental lesions at Liver MRI and CEUS It will address the topic of MR imaging of benign lesions.

Unlocking the AI Revolution Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”

Bracco Imaging announces global agreement with Subtle Medical Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI.

Bracco Imaging has won the Gold Medal from EcoVadis The company is now proudly sporting the EcoVadis gold medal for what it has managed to achieve in four key areas: environment, ethics, labour and human rights, sustainable procurement.